文献速递细胞病理与分子病理神经与头颈病理

DICER1突变甲状腺肿瘤的细胞病理学特征

[Cytopathological features of thyroid tumors with DICER1 mutation].
PubMed 文献 · Zhonghua Bing Li Xue Za Zhi · 2025-01-01

回顾性分析上海六院2022年5月至2024年11月163例组织形态提示DICER1突变行Sanger测序的甲状腺肿瘤,15例(9.2%)证实突变。细胞学以巨滤泡结构为主、核小而圆深染,术前诊断多为Ⅱ类或Ⅳ类,难以识别典型萎缩滤泡。

要点

  • DICER1突变甲状腺肿瘤细胞学以巨滤泡结构为主,核小而圆深染。
  • 细胞涂片难以见典型诊断性萎缩滤泡,术前常诊断为良性或不确定类别。
  • 需仔细观察巨滤泡和小圆深染核,提示行DICER1基因检测以明确诊断。

核心结论

  • DICER1突变甲状腺肿瘤细胞形态以巨滤泡为主,核小而一致深染,术前细胞学多归为良性非肿瘤或不确定类别。

研究设计与样本

  • 回顾性研究,收集2022年5月至2024年11月上海交通大学医学院附属第六人民医院病理科163例组织形态提示DICER1突变并行Sanger测序的甲状腺肿瘤病例。

主要发现

  • 163例中15例证实DICER1突变(15/163,9.2%),其中女14例、男1例,年龄42(31,47)岁。
  • 8例为D1709热点突变(8/15),7例为E1813热点突变(7/15),不同热点突变率差异无统计学意义(F=0.620,P=0.438)。
  • 所有样本细胞量中等,以巨滤泡结构为主,小乳头状结构罕见;细胞核多圆而一致、深染,略增大至中等大小;3例易见核沟。
  • 按甲状腺细针穿刺细胞学诊断专家共识(2023版)分类:Ⅱ类6例、Ⅲ类2例、Ⅳ类6例、Ⅴ类1例。
  • 术后组织病理诊断:滤泡癌2例、高级别分化型甲状腺癌1例、滤泡腺瘤3例、恶性潜能未定甲状腺肿瘤4例、滤泡结节性病变5例。

关键数值与推荐

  • 细胞学诊断分类依据甲状腺细针穿刺细胞学诊断专家共识(2023版)报告系统。

临床怎么用

  • 细胞病理诊断中需仔细观察巨滤泡结构和小而一致深染的细胞核特征。
  • 对于术前提示分子检测并明确诊断DICER1突变十分必要。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the cytopathological features of thyroid tumor with DICER1 mutation. Methods: A retrospective study on the preoperative cell smear was conducted on thyroid tumors with DICER1 gene mutations detected by Sanger sequencing in the Department of Pathology Shanghai Sixth People's Hospital affiliated to Shanghai Jiaotong University School of Medicine from May 2022 to November 2024. Results: Totally 163 cases with histological features indicating DICER1 mutation related thyroid tumor underwent Sanger sequencing. Fifteen cases were confirmed to harbor DICER1 mutation (15/163,9.2%). Fourteen of 15 patients were female, and only 1 was male; average age 42(31,47) years. Eight cases presented with D1709 hotspot mutation (8/15) and 7 cases with the E1813 hotspot mutation (7/15) and there was no statistical significant difference between mutation rate of different hotspot (F=0.620,P=0.438). All specimens were stained with hematoxylin-eosin staining. A moderate number of cells were observed for all cases, predominantly with macrofollicular pattern and rare small papillae. The cell nuclei were mainly uniform, small, round and dark, slightly enlarged or medium-sized. Several cases could also present RAS-like nuclear features: 3 cases showed visible nuclear grooves. According to the expert consensus on the cytopathological diagnosis of thyroid fine needle aspiration (version 2023),the cytopathological diagnostic categories were: Ⅱ, 6 cases; Ⅲ, 2 cases; Ⅳ, 6 cases; and Ⅴ, 1 case. Postoperative histological diagnoses included follicular thyroid carcinoma in 2 cases, high-grade differentiated thyroid carcinoma in 1 case, follicular thyroid adenoma in 3 cases, follicular thyroid tumor of undetermined malignant potential in 4 case, and thyroid follicular nodular disease in 5 cases. Conclusions: The morphological features of DICER1-mutated thyroid tumors are predominant macrofollicles, with uniformly small round and dark nuclei. It is difficult to identify typically diagnostic atrophic follicles on cell smear, leading to a preoperative diagnosis of benign non-neoplastic or indeterminate category. Therefore, it is necessary to carefully observe the macro-follicles and small round dark nuclear features, which is necessary to suggest a genetic test of DICER1 gene and to confirm the diagnosis before surgery. 目的: 探讨DICER1基因突变甲状腺肿瘤细胞病理学特征。 方法: 收集2022年5月至2024年11月上海交通大学医学院附属第六人民医院病理科确诊的DICER1基因突变甲状腺肿瘤,观察其细胞病理形态,分析不同位点突变频率的差异。 结果: 共163例患者因组织形态提示DICER1基因突变而行Sanger测序,其中15例证实存在DICER1基因突变(15/163,9.2%)。15例患者中14例为女性,1例为男性;患者年龄42(31,47)岁。8例患者为D1709热点突变(8/15)、7例为E1813热点突变(7/15),不同热点突变率差异无统计学意义(F=0.620,P=0.438)。涂片均为细胞涂片、HE染色。所有样本细胞量中等,以巨滤泡结构为主,小乳头状结构罕见。细胞核多圆而一致、深染,略增大至中等大小。少数表现为RAS样核特征为主,3例易见核沟。根据甲状腺细针穿刺细胞学诊断专家共识(2023版)病理报告系统诊断分类为:Ⅱ类6例,Ⅲ类2例,Ⅳ类6例,Ⅴ类1例。术后组织病理诊断包括:甲状腺滤泡癌2例,高级别分化型甲状腺癌1例,甲状腺滤泡腺瘤3例,恶性潜能未定的甲状腺肿瘤4例,甲状腺滤泡结节性病变5例。 结论: DICER1基因突变甲状腺肿瘤形态学以巨滤泡结构为主,细胞核多小而一致深染;细胞学上难以发现典型诊断性萎缩的滤泡,导致术前细胞学诊断以良性非肿瘤和不确定类型病变为主。细胞病理诊断中需仔细观察巨滤泡结构和小而一致深染的细胞核特征,对于术前提示分子检测并明确诊断十分必要。.

来源:Zhonghua Bing Li Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wu L, Jiao Q, Tang J, et al. [Cytopathological features of thyroid tumors with DICER1 mutation]. Zhonghua Bing Li Xue Za Zhi. 2025. PMID: 40302583. doi:10.3760/cma.j.cn112151-20241125-00783

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。